Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Nature Careers
- Umeå University
- University of Maryland, Baltimore
- Stanford University
- University of Washington
- Baylor College of Medicine
- University of North Carolina at Chapel Hill
- University of Minnesota
- Duke University
- University of Utah
- Cornell University
- Harvard University
- The Ohio State University
- University of Oslo
- University of Oxford
- VIB
- Washington University in St. Louis
- Aarhus University
- CNRS
- FAPESP - São Paulo Research Foundation
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- New York University
- Pennsylvania State University
- Rutgers University
- Stony Brook University
- University of Southern Denmark
- University of Virginia
- Argonne
- CIML2000
- CRAG-Centre de Recerca Agrigenòmica
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Central State University
- Delft University of Technology (TU Delft)
- EURECAT
- Emory University
- Gustave Roussy / Inserm
- Indiana University
- Institut Jacques Monod, CNRS UMR 7592
- Institut Pasteur
- Joseph B Sweeney
- KU LEUVEN
- Karolinska Institutet (KI)
- King's College London
- Leibniz
- Massachusetts Institute of Technology
- Max Planck Institute for Multidisciplinary Sciences, Göttingen
- Medical University of Gdańsk
- National Institute of Chemistry Slovenia
- Purdue University
- RIKEN
- Rice University
- Sanofi
- SciLifeLab
- THE UNIVERSITY OF HONG KONG
- Technical University of Denmark
- Texas A&M AgriLife
- Texas A&M University
- The University of Arizona
- The University of Western Australia
- UNIVERSITY OF HELSINKI
- Umeå universitet
- Umeå universitet stipendiemodul
- Universidade de Coimbra
- Universite de Montpellier
- University College Dublin
- University of California, Los Angeles
- University of Dundee;
- University of Glasgow
- University of Kentucky
- University of London
- University of Lund
- University of Luxembourg
- University of Miami
- University of Nebraska Medical Center
- University of Newcastle
- University of Oxford;
- University of Sydney
- University of Texas at Dallas
- University of Tübingen
- Utrecht University
- Vrije Universiteit Amsterdam (VU)
- Wageningen University & Research
- Zintellect
- 73 more »
- « less
-
Field
-
. What we work on: CRISPR screening at scale: We co-developed the Perturb-seq approach for conducting single-cell CRISPR screens. We’ve since scaled this technology to target every gene in the genome and
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
immune activation, cytotoxicity, and persistence. Additional methods may involve CRISPR-based perturbations, viral vector engineering, and immune cell manufacturing workflows relevant to CAR-based
-
-fluorescence microscopy, flow cytometry and immunoblotting. CrispR cas9 is routinely used to create mammalian cell knockouts. RNAseq and proteomics-based approaches are also anticipated. Work will involve
-
for analysis of large-scale whole genome genetic and genomic and phenotype data. Examples include large Whole Genome Sequencing association studies, biobanks, single-cell and CRISPR multiome data, integrative
-
elements and regulatory factors control gene expression in both physiological and disease contexts. Current projects leverage ReLiC, a high-throughput CRISPR screening platform that we recently developed
-
on isolated mutations in patients with telomeric disorders Construction of KI cell lines using CRISPR-Cas9 Characterization of the telomeric phenotypes of these KI lines Characterization of the phenotypes
-
DNA from soils Carry out library preparation for long read sequencing Use CRISPR-Cas to edit genomes of common soil bacteria Establish and maintain cultures of common freshwater Cyanobacteria This role
-
high-resolution confocal and live-cell imaging approaches. Working with human and mammalian cell lines, you will investigate virus–host interactions using molecular biology, virology, CRISPR/siRNA-based
-
perturbation strategies, including CRISPR-based gene editing and pharmacological inhibition, to identify mechanistic vulnerabilities in disease-relevant contexts. The candidate will contribute to experimental